Regarding the contraindications, the presence of minor components in IVIg formulations may constitute a caveat, such as glucose for diabetics, sucrose for kidney disease, and high IgA concentrations for subjects prone to allergic reactions (Lemm, 2002). The gene discussed is CD79A; the disease is allergic disease.